HIV genotyping study launched in Brazil
This article was originally published in Clinica
Executive Summary
Brazil is to launch a study to assess drug resistance in the HIV-1 virus genome, as part of the country's first major evaluation of the clinical utility of routine genotyping. The one-year study will involve 6,000 patients who have twice failed to respond to the Highly Active AntiRetroviral Therapy (HAART) drug combination regime.